Addor Capital Leads $35M New Round In CoWin Biosciences

Chinese biological reagent developer CoWin Biosciences has completed a RMB245 million (US$35.86 million) new round financing led by Addor Capital with participation from Green Pine Capital Partners and Share Capital. Founded in 2007, CoWin Biosciences provides high quality biology reagents in life science research and molecular diagnostics field. It serves global scientific research institutes, universities, […]

Addor Capital Leads $35M New Round In CoWin Biosciences comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.

Read the original article: China Money Network